共 40 条
[1]
Sowers J.R., Epstein M., Frolich E., Diabetes, hypertension and cardiovascular disease: An update, Hypertension, 37, pp. 1053-1059, (2001)
[2]
Douglas J.G., Clinical guidelines for the treatment of hypertension in African Americans, Am J Cardiovasc Drugs, 5, pp. 1-6, (2005)
[3]
Chobanian A.V., Bakris G.L., Black H.R., Et al., The Seventh Report of the National Committee Prevention, Detection, Evaluation and Treatment of High Blood Pressure, Hypertension, 42, pp. 1206-1252, (2003)
[4]
K/Doqi Clinical Practice guidelines on hypertension and antihypertensive agents in chronic kidney disease, Am J Kidney Dis, 43, SUPPL. 1, (2004)
[5]
Mann J.F., Gerstein H.C., Pogue J., Et al., Renal insufficiency as a predictor of cardiovascular outcomes and the impact of Ramipril: The HOPE randomized trial, Ann Intern Med, 134, pp. 629-636, (2001)
[6]
Shulman N.B., Fold C.E., Hall W.D., Et al., Prognostic value of serum creatinine and effect of treatment of hypertension on renal function, Hypertension, 13, SUPPL. 5, pp. 180-193, (1989)
[7]
Walker W.G., Neaton J.D., Cutler J.A., Et al., Renal function change in hypertensive members of the Multiple Risk Factors Intervention Trial. Racial and treatment effects, J Am Med Assoc, 268, pp. 3085-3091, (1992)
[8]
Peterson J.C., Adler S., Burkart J.M., Et al., Blood pressure control, proteinuria and the progression of renal disease. The Modification of Diet in Renal Disease Study, Ann Intern Med, 123, pp. 754-762, (1995)
[9]
Bakris G.L., William M., Dworkin L., Et al., Preserving kidney function in adults with hypertension and diabetes: A consensus approach, Am J Kidney Dis, 36, pp. 646-661, (2000)
[10]
Perry Jr. H.M., Miller J.P., Fornoff J.R., Et al., Early predictors of 15-year end-stage renal disease in hypertensive patients, Hypertension, 25, pp. 587-594, (1995)